Home/Filings/3/0001192482-20-000311
3//SEC Filing

BioXcel Holdings, Inc. 3

Accession 0001192482-20-000311

CIK 0001720893other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 5:12 PM ET

Size

4.7 KB

Accession

0001192482-20-000311

Insider Transaction Report

Form 3
Period: 2020-04-23
Holdings
  • Common Stock

    (indirect: See Footnote)
    9,180,000
Footnotes (1)
  • [F1]These securities are held of record by BioXcel LLC. As of April 23, 2020 BioXcel LLC is a subsidiary of the Reporting Person, by virtue of which the Reporting Person may be deemed to have voting and investment power with respect to the securities held by BioXcel LLC and as a result may be deemed to have beneficial ownership over such securities. Each of the Reporting Person and BioXcel LLC disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Issuer

BioXcel Therapeutics, Inc.

CIK 0001720893

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001811154

Filing Metadata

Form type
3
Filed
May 3, 8:00 PM ET
Accepted
May 4, 5:12 PM ET
Size
4.7 KB